Verona Pharma to Present Clinical Trial Data of Ensifentrine for COPD Maintenance Treatment at American Thoracic Society 2019 International Conference

    NEXT STORY
    Intellia Therapeutics Announces First Quarter 2019 Financial Results and Company Update
    PREV STORY
    Teleflex Reports First Quarter 2019 Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Affimed Highlights Progress on NK Cell Engager Collaboration with Genentech

    author_avatar
    NASDAQ Market News

    ABLYNX ANNOUNCES CONVERSION OF BONDS

    REGULATED INFORMATION GHENT, Belgium, 28 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] ...

    author_avatar
    NASDAQ Market News

    ACR 2019: Lilly Presents Positive New Data from COAST-X, a Phase 3 Study of TALTZ® (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis

    author_avatar
    NASDAQ Market News